Maternal glucocorticoids critically rise during pregnancy reaching up to a 20-fold increase of
mid-pregnancy concentrations. Concurrently, another steroid hormone, progesterone …

The COVID-19 pandemic is acutely threatening access to essential health services,
including abortion [1]. Across all fields of medicine, changes in practice models are …

Abortion and miscarriage are common, affecting millions of US women each year. By age
45, one in four women in the USA will have had an abortion, and at least as many will have …

Objectives This open-label non-inferiority study assessed efficacy of a common outpatient
medical abortion regimen among people with pregnancies 64–70 days and 71–77 days of …

OBJECTIVE: To estimate the efficacy and safety of mifepristone antagonization with high-
dose oral progesterone. METHODS: We planned to enroll 40 patients in a double-blind …

Abnormal uterine bleeding (AUB) is a chronic, debilitating and common condition affecting
one in four women of reproductive age. Current treatments (conservative, medical and …

Medication regimens using mifepristone and misoprostol are safe and effective for outpatient
treatment of early pregnancy loss for up to 84 days' gestation and for medication abortion up …

Medical abortion is a common method to terminate an early pregnancy and often causes
serious complications such as abnormal uterine bleeding and endometritis. Buxue Yimu …

Introduction Numerous studies have been performed assessing optimal treatment regimens
for evacuating (retained) products of conception from the uterus, but standardized criteria for …

Background Australia has demonstrated high efficacy and safety of medical termination of
pregnancy (MToP) using a mifepristone–buccal misoprostol regime. The provision of …